US Patent 10,213,392 — assignment history and current owner

US 10,213,392 · Application 15/648,314

Pharmaceutical Composition For Use In Medical And Veterinary Ophthalmology

Who owns US Patent 10,213,392?

US10213392 ("Pharmaceutical Composition For Use In Medical And Veterinary Ophthalmology") — current assignee: ESSEX BIO-INVESTMENT LIMITED. Status: Active, estimated expiration June 10, 2029. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 10,213,392 is ESSEX BIO-INVESTMENT LIMITED. Based on the most recent ownership transfer record (recorded 2023-04-13).

Patent title
Pharmaceutical Composition For Use In Medical And Veterinary Ophthalmology
Application number
15/648,314
Apparent operating assignee
ESSEX BIO-INVESTMENT LIMITED
Patent status
Active, estimated expiration June 10, 2029
Recorded assignments
2

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Dec 12, 2017Dec 21, 2017Ownership TransferSKULACHEV, MAXIM V.MITOTECH SA44456/442
Oct 13, 2022Apr 13, 2023Ownership TransferMITOTECH S.A.ESSEX BIO-INVESTMENT LIMITED63312/574

Scrolls sideways on narrow screens

Chain of title

In 2017, SKULACHEV, MAXIM V. assigned the patent to MITOTECH SA. The most recent ownership transfer, recorded in 2023, lists ESSEX BIO-INVESTMENT LIMITED as assignee.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 15/648,314 · US 10,213,392

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 10,213,392, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.